Becton Dickinson up on 2022 profit forecast raise
** Becton Dickinson and Co's shares BDX.N up 4.19% at $255
** Medical-device maker revises its 2022 adjusted profit
forecast to $11.28 to $11.35 per share from $11.15 to $11.30
** Raises 2022 sales forecast to $18.75 bln to $18.83 bln vs
$18.5 bln to $18.7 bln earlier
** The outlook reflects sales of up to $500 million in
COVID-19-only diagnostic testing increase from prior forecast of
$450 million
** Including session gains, stock up ~3% YTD
(Reporting by Khushi Mandowara)
((Khushi.Mandowara@thomsonreuters.com;))
Recent news on Becton Dickinson and Co
See all newsCorrected: BDx secures data center power contract from Indonesia's PLN
China's commerce ministry holds meeting with foreign pharmaceutical firms
Brief: Becton Dickinson Euro Finance S.À R.L Files For Euro-Denominated 600 Million 3.855% Notes Offering Due 2033 - SEC Filing
U.S. STOCKS ON THE MOVE-Krispy Kreme, Tesla, Axon Enterprise
Becton Dickinson raises 2026 profit forecast on drug delivery devices demand (updated)